Todd Harris - 05 May 2026 Form 4 Insider Report for Tyra Biosciences, Inc. (TYRA)

Reporting relationship: President and CEO, Director
Issuer ticker: TYRA
Reported as of: 05 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 07 May 2026, 16:30:09 UTC
Prior SEC filing: 17 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Ali D. Fawaz, Attorney-in-Fact

Key filing fact

Todd Harris filed Form 4 for Tyra Biosciences, Inc. (TYRA) on 07 May 2026.

Key facts

This page summarizes Todd Harris's Form 4 filing for Tyra Biosciences, Inc. (TYRA).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 07 May 2026, 16:30.

Change

Previous filing in this sequence was filed on 17 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001711463 Primary reporting owner

Harris Todd

Relationship: President and CEO, Director
Address: C/O TYRA BIOSCIENCES, INC., 2656 STATE STREET, CARLSBAD
Signature: /s/ Ali D. Fawaz, Attorney-in-Fact
Signature date: 07 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TYRA transaction

Common Stock

Award

Transaction value
Shares: +79,000
Change %: +5.8%
Price: $0.000000^*
Shares after: 1,437,631
Date: 05 May 2026
Ownership: Direct
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TYRA transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares: +265,000
Change %
Price: $0.000000^*
Shares after: 265,000
Date: 05 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 265,000
Exercise price: $33.93
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents restricted stock units ("RSUs") granted on May 5, 2026. 1/4 of the total number of RSUs granted vest on each of the first four anniversaries of May 5, 2026, the vesting commencement date, subject to the Reporting Person's continuous service through each vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.

Footnote F2

Includes RSUs.

Footnote F3

1/48th of the shares subject to the option vest monthly following May 5, 2026, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date.